University of Virginia Health System

When can kids return to sports after COVID-19? Doctors weigh in

Newswise — A trio of pediatric cardiologists is offering important advice on if and when it is safe for children and teens to return to playing sports after recovering from COVID-19.

The doctors, including UVA Health’s Peter Dean, MD, say that in most cases – especially asymptomatic cases – children should be able to return to sports two weeks after recovering. But they warn against a one-size-fits-all approach, especially for youths who get very sick, and they stress the importance of ensuring recovering student-athletes cannot spread the disease further.  

“COVID-19 has been shown to cause significant heart damage in adults, and because of this, the adult guidelines are recommending several cardiac tests before returning to sports and physical activity,” said Dean, a cardiologist at UVA Children’s. “Fortunately, since children seem to be less impacted by COVID-19 and their level of exercise intensity is less, pediatric providers should be able to more easily clear patients without extensive cardiac testing in mild cases.”

In addition to Dean, the new guidance comes from Lanier Burns Jackson, MD, of Medical University of South Carolina, and Stephen M. Paridon, MD, of Children’s Hospital of Philadelphia. (Dean and UVA Health’s Robert Battle, MD, have been working with the UVA Sports Medicine team led by John MacKnight, MD, to clear UVA athletes to return to participation after COVID-19 infections.)

COVID-19 and Cardiac Damage

The guidance is meant for physicians but will have important implications for many families this fall. Most COVID-19 cases in children are mild or asymptomatic, the doctors note, but severe cases can occur. In those cases, doctors and families must proceed cautiously.

“The question of returning to sports is significant because of the propensity for COVID-19 to cause cardiac damage and myocarditis,” a serious heart inflammation, the authors write for the American College of Cardiology’s website, “While the incidence of myocarditis is lower in the pediatric population compared to the adult population, myocarditis is known to be a cause of sudden death during exercise in the young athletic populations.”

In the rare case when a child or teen is hospitalized, has abnormal cardiac tests during the infection or suffers “multisystem inflammatory syndrome in children” caused by COVID-19, more cardiac testing is required, the doctors say. Such children may need to be kept out of sports for three to six months, and they should only return to the field if cardiac testing and other metrics come back normal, the cardiologists advise.  

Children who have mild infections, on the other hand, should be able to return to practice two weeks after their last symptoms disappear. “Patients should be asymptomatic for at least two weeks,” the doctors emphasize. “This two-week period will allow for the full clinical manifestations of COVID-19 to present themselves and, perhaps most importantly, decrease the risk of transmitting the infection to teammates or opponents.”

In the middle of the spectrum are pediatric patients who have “moderate” symptoms of COVID-19 but do not become seriously ill. These are children and teens who may have prolonged fevers, for example. Doctors need to assess these patients on a case-by-case basis, and they should consider the type and intensity of sports the patients play. “Providers should not treat the 7-year-old recreational soccer player the same as the 18-year-old varsity basketball player,” the cardiologists say.

High-school and college athletes who have moderate COVID-19 symptoms may warrant cardiac testing before returning to the field, but younger children likely will not, the doctors advise.

Player Precautions

As a precautionary measure, the cardiologists recommend that youth sports and high-school athletics programs ensure defibrillators, CPR and medical care are available during sporting events.

“Most pediatric patients should be fairly easily cleared to resume sports after a COVID-19 infection, but there will be rare cases where more extensive cardiac testing is required,” Dean said. “We also expect to learn more about the long-term cardiac implications of the virus in the next several months to years, so it is important to stay up-to-date with information.”

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.

MORE ON COVID-19: Blood test can predict disease severity.


Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Showing results

110 of 3327